Biomet's elbow replacement showing promise; University of Michigan team wins pediatric device competition;

@FierceMedDev: ICYMI: Drug-device combo from Wyss takes a new approach on treating stroke. FierceBiotechResearch story | Follow @FierceMedDev

@EmilyWFierce: Flowonix teams with Connecticut provider for implant of drug delivery infusion pump. Article | Follow @EmilyWFierce

> The co-designer of Biomet's Comprehensive Segmental Revision System for total elbow arthroplasty said it is improving patient outcomes and described a case study of a patient treated at the Cleveland Clinic. More

> Pediatric innovation fellows from the University of Michigan won $50,000 in the 5th Annual Atlantic Pediatric Device Consortium Innovation Competition. They are developing a low-profile enteral feeding device for children. Enteral tubes are implanted in the abdomen and provide nutrition to those who cannot intake food orally. More

Biotech News

@FierceBiotech: ICYMI yesterday: Merck KGaA inks cancer metabolism drug discovery alliance with Selvita. Article | Follow @FierceBiotech

@JohnCFierce: Gates, Hopp back $110M megaround for CureVac's mRNA work. News | Follow @JohnCFierce

@DamianFierce: Wait can we reconvene Grantland just to deal with this image? More | Follow @DamianFierce

> Sanofi inks a $1.5B deal to join BioNTech's growing list of oncology partners. Story

> GSK forms Keytruda combo trial pact as it plots path to 20 filings by 2020. Article

Pharma News

@FiercePharma: ICYMI yesterday: FDA cites Pfizer for shortfalls at Chinese manufacturing plant. Article | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Express Scripts looks into pharmacies at AbbVie, Teva in wake of Valeant's Philidor saga. Article | Follow @CarlyHFierce

> In snit over supply, not prices, MSF urges South Africa to override AbbVie drug patent. Article

> Pfizer flirted with a GSK megabid, but got rejected: FT. Story

Drug Delivery News

> Amgen's Imlygic becomes first re-engineered virus to earn FDA approval as a cancer fighter. Item

> Pfizer's sickle cell anemia candidate enters trials, to the delight of delivery partner Halozyme. Story

> Imaging nanoparticle puts the heat to ovarian cancer cells. Article

> Investigational drug enables faster absorption of bioresorbable drug-eluting stents. Report

> Novartis' inhaler for COPD gets FDA approval. More

Pharma Manufacturing News

> Bain-backed compounding upstart adds second Texas manufacturing facility. Item

> Struggling Daiichi again stumbles with vaccine production. More

> First prefab biologics plant goes up in China, in 11 days. Report

> Roche completes Shanghai plant expansion, starts on new project. Story

> FDA uncovers issues at Pfizer China plant after banning products from its JV partner. Article

Pharma Asia News

> China State Council briefing outlines multilevel system for medical treatment. More

> MabSpace gets $15M as Lilly Asian Ventures bets on immune approach. Story

> China's WuXi PharmaTech, Gilead focus on analytical testing in wider partnership. Article

> HK-based Chi-Med wraps up PhI healthy volunteer trial of HMPL 523. More

> China's Biomab Holding, India's Cipla go separate ways on biosimilars. Report

Suggested Articles

BD will begin offering a point-of-care COVID-19 antibody assay, which operates like a combination of a blood glucose test and a home pregnancy test.

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.